M-A | Proactive therapeutic drug monitoring vs. conventional management for inflammatory bowel diseases.
18 Oct, 2022 | 12:42h | UTC
Commentary on Twitter
October's Editor's Essential Reading examines proactive therapeutic drug monitoring versus conventional management for inflammatory bowel diseases @vipuljairath @ChrisMa_YYC https://t.co/kNAia4yowO pic.twitter.com/wfgQSQtM1O
— Gastroenterology (@AGA_Gastro) September 28, 2022